Sulthiame is an investigational, generally well-tolerated oral carbonic anhydrase inhibitor that is designed to restore breathing stability which is often a contributing mechanism in people with OSA.

Carbonic anhydrase inhibitors show promise in reducing tau protein buildup and neurodegeneration, paving the way for new treatments in neurodegenerative diseases. In a recent study published in ...

Opening the door to wider treatment access and faster adoption of oral therapies for obstructive sleep apnea (OSA) and other ...

Paper Summary Methodology This study explored whether carbonic anhydrase (CA) inhibitors could reduce tau protein toxicity, a ...

These eye drops contain dorzolamide and/or brinzolamide, which are carbonic anhydrase inhibitors, prohibited at all times according to the WADA Prohibited List (in the category of diuretics and ...